Literature DB >> 10950478

Hepatic encephalopathy associated with combined clozapine and divalproex sodium treatment.

W C Wirshing, D Ames, S Bisheff, J M Pierre, A Mendoza, A Sun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 10950478     DOI： 10.1097/00004714-199704000-00013

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Seizure associated with clozapine: incidence, etiology, and management.

Authors:  Andrew M Williams; Susie H Park
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

3.  Clozapine-induced fatal fulminant hepatic failure: a case report.

Authors:  Albert Chang; Darin S Krygier; Nazira Chatur; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2009-05       Impact factor: 3.522

Review 4.  Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.

Authors:  Mahmoud Slim; Inmaculada Medina-Caliz; Andres Gonzalez-Jimenez; M Rosario Cabello; Fermin Mayoral-Cleries; M Isabel Lucena; Raul J Andrade
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 5.  Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.

Authors:  Diogo Telles-Correia; António Barbosa; Helena Cortez-Pinto; Carlos Campos; Nuno B F Rocha; Sérgio Machado
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.